Home
Find an Article
Volume 27 – 2022 Articles
Number 4: JUL-AUG 2022
Number 3: MAY-JUN 2022
Number 2: MAR-APR 2022
Number 1: JAN-FEB 2022
Volume 26 – 2021 Articles
Number 6: NOV-DEC 2021
Number 5: SEP-OCT 2021
Number 4: JUL-AUG 2021
Number 3: MAY-JUN 2021
Number 2: MAR-APR 2021
Number 1: JAN-FEB 2021
Volume 25 – 2020 Articles
Number 5: NOV-DEC 2020
Number 4: SEP-OCT 2020
Special Edition – June 2020
Number 3: MAY-JUN 2020
Number 2: MAR-APR 2020
Number 1: JAN-FEB 2020
OLDER ARCHIVES
STL Editions
Dermatology
Family Practice
Pharmacist
Conditions
Acne
Eczema
Psoriasis
Skin Cancer
Fungal Infections
Rosacea
Aging Skin
Cosmetic Dermatology
Contributors
Videos
Downloads
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Find an Article
Volume 27 – 2022 Articles
Number 4: JUL-AUG 2022
Number 3: MAY-JUN 2022
Number 2: MAR-APR 2022
Number 1: JAN-FEB 2022
Volume 26 – 2021 Articles
Number 6: NOV-DEC 2021
Number 5: SEP-OCT 2021
Number 4: JUL-AUG 2021
Number 3: MAY-JUN 2021
Number 2: MAR-APR 2021
Number 1: JAN-FEB 2021
Volume 25 – 2020 Articles
Number 5: NOV-DEC 2020
Number 4: SEP-OCT 2020
Special Edition – June 2020
Number 3: MAY-JUN 2020
Number 2: MAR-APR 2020
Number 1: JAN-FEB 2020
OLDER ARCHIVES
STL Editions
Dermatology
Family Practice
Pharmacist
Conditions
Acne
Eczema
Psoriasis
Skin Cancer
Fungal Infections
Rosacea
Aging Skin
Cosmetic Dermatology
Contributors
Videos
Downloads
Skin Therapy Letter
Advertisement
Ooops... Error 404
Sorry, but the page you are looking for doesn't exist.
You can go to the
HOMEPAGE
OUR LATEST POSTS
Dermatology
Casmo Algorithm for Management of Hormonal Therapy-Related Cutaneous Adverse Effects in...
Psoriasis
IL-23s: Psoriasis therapy overview
Psoriasis
Selecting from IL-23s
Psoriasis
Tildrakizumab candidates
Psoriasis
Tildrakizumab effectiveness related to trial results
Psoriasis
Tildrakizumab effectiveness
